iKang Schedules 2016 Unaudited Fourth Quarter and Fiscal Year Earnings Release on June 22, 2017
May 25 2017 - 4:05PM
iKang Healthcare Group, Inc. (“iKang” or the “Company”)
(Nasdaq:KANG), major provider in China’s fast growing private
preventive healthcare services market, today announced that it will
release its unaudited financial results for the fourth quarter and
the fiscal year ended March 31, 2017 on June 22, 2017 after the US
market closes.
The earnings press release will be available on
the investor relations page at http://ir.ikang.com.
Conference CalliKang’s
management will host a conference call at 8:00 am US
Eastern Time (8:00 pm Beijing/Hong Kong Time) on June 23,
2017, to discuss its quarterly and fiscal year results and recent
business activities.
To participate in the conference call, please
dial the following number five to ten minutes prior to the
scheduled conference call time:
China: |
|
|
4001-200-539 |
Hong
Kong: |
|
|
800-905-927 |
United States: |
|
|
1855-298-3404 |
International: |
|
|
+65
6823-2299 |
Passcode: |
|
|
1216526 |
The Company will also broadcast a live audio
webcast of the conference call. The webcast will be available at
http://ir.ikang.com.
Following the earnings conference call, an archive of the call
will be available by dialing:
China: |
|
|
4001-842-240 |
Hong
Kong: |
|
|
800-966-697 |
United States: |
|
|
1866-846-0868 |
International: |
|
|
+61-2-9641-7900 |
Replay Passcode: |
|
|
1216526 |
Replay End Date: |
|
|
July
7, 2017 |
About iKang Healthcare Group,
Inc.
iKang Healthcare Group, Inc. is one of the
largest providers in China’s fast-growing private preventive
healthcare space through its nationwide healthcare services
network.
iKang’s nationwide integrated network of
multi-brand self-owned medical centers and third-party facilities,
provides comprehensive and high-quality preventive healthcare
solutions across China, including medical examination, disease
screening, outpatient service and other value-added services.
iKang’s customer base primarily comprises corporate clients, who
contract with iKang to deliver medical examination services to
their employees and clients, and receive these services at
pre-agreed rates. iKang also directly markets its services to
individual customers. In the fiscal year ended March 31, 2016,
iKang served a total of 4.6 million customer visits under both
corporate and individual programs.
As of May 25, 2017, iKang has a nationwide
network of 108(1) self-owned medical centers, covering
33 of China’s most affluent cities: Beijing, Shanghai, Guangzhou,
Shenzhen, Chongqing, Tianjin, Nanjing, Suzhou, Hangzhou, Chengdu,
Fuzhou, Changchun, Jiangyin, Changzhou, Wuhan, Changsha, Yantai,
Yinchuan, Weihai, Weifang, Shenyang, Xi’an, Wuhu, Guiyang, Ningbo,
Foshan, Jinan, Bijie, Qingdao, Wuxi, Kaili and Mianyang, as well as
Hong Kong. iKang has also extended its coverage to over 150 cities
by contracting with approximately 400 third-party facilities, which
including select independent medical examination centers and
hospitals across all of China’s provinces, creating a nationwide
network that allows iKang to serve its customers in markets where
it does not operate its own medical centers.
(1) Among the 108 self-owned medical centers,
two medical centers are currently operated primarily by the
minority shareholders of these medical centers or their parent
company.
Forward-looking Statements
This press release contains forward-looking
statements. These statements, including management quotes and
business outlook, are made under the “safe harbor” provisions of
the U.S. Private Securities Litigation Reform Act of 1995. These
forward-looking statements can be identified by terminology such as
”will,” "estimate," "project," "predict," "believe," "expect,"
"anticipate," "intend," "potential," "plan," "goal" and similar
statements. iKang may also make written or oral
forward-looking statements in its periodic reports to the U.S.
Securities and Exchange Commission, in its annual report to
shareholders, in press releases and other written materials and in
oral statements made by its officers, directors or employees to
third parties. Such statements involve certain risks and
uncertainties that could cause actual results to differ materially
from those expressed or implied in the forward-looking statements.
These forward-looking statements include, but are not limited to,
statements about: the Company’s goals and strategies; its future
business development, financial condition and results of
operations; its ability to retain and grow its customer base and
network of medical centers; the growth of, and trends in, the
markets for its services in China; the demand for and market
acceptance of its brand and services; competition in its industry
in China; relevant government policies and regulations relating to
the corporate structure, business and industry; fluctuations in
general economic and business conditions in China. Further
information regarding these and other risks is included in iKang’s
filing with the Securities and Exchange Commission. iKang
undertakes no duty to update any forward-looking statement as a
result of new information, future events or otherwise, except as
required under applicable law.
IR Contact:
iKang Healthcare Group, Inc.
Christy Xie
Director of Investor Relations
Tel: +86 10 5320 8599
Email: ir@ikang.com
Website: www.ikanggroup.com
FleishmanHillard
Ruby Yim
Email: ikang@fleishman.com
IKANG HEALTHCARE GROUP, INC. (NASDAQ:KANG)
Historical Stock Chart
From Apr 2024 to May 2024
IKANG HEALTHCARE GROUP, INC. (NASDAQ:KANG)
Historical Stock Chart
From May 2023 to May 2024